← Back to headlines
AstraZeneca Navigates China Challenges Amid New Drug Launches
Pharmaceutical giant AstraZeneca is reportedly facing significant business challenges in China while preparing for key drug launches. Despite these headwinds, two banks are projecting a 20% upside for the company's stock.
10 Apr, 14:31 — 10 Apr, 14:31
Sources
Showing 1 of 1 sources
Related Stories
Oldest Plague Outbreak Discovered in Siberia, Dating Back 5,500 Years
just now
Extreme Training: What Heat Training Does to the Body
just now
AIIMS Cardiologist Highlights Scientific Evidence for Yoga in Preventive Healthcare
56m ago
Nearly 300 Hospitalized in Vietnam Due to Salmonella from Banh Mi Shop
1h ago